Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Internal Medicine
Endocrinology
Questions discussed in this category
What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?
1 Answer available
20876
Papers discussed in this category
N Engl J Med,
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Autoimmunity reviews, 2023 Dec 20
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study.
Related Topics in Internal Medicine
Rheumatology
General Rheumatology
JAK Inhibitors
Cardiovascular disease
Dermatology
Endocrinology
Lipid Disorders